Imagenomix AI

Curated by Signal

AI based platform offering solutions for cancer diagnosis and treatment

Overview

AI based platform offering solutions for cancer diagnosis and treatment. It leverages AI driven recognition software to enhance access to cancer diagnostic results. The platform utilizes AI models to link pathology images to genotypes and clinical outcomes, enhancing the precision and speed of cancer testing. It aims to deliver rapid diagnostic results, enhancing patient outcomes and treatment options.

Key facts

Founded: 2022
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Engaging Smiles
Provider of digital marketing tool for dental practices
Health TechnologyMckinney, United States
Apogee Informatics
Cloud based SaaS platform for patient flow management
Health TechnologyMadison, United States
MediConnect Global
Provider of a SaaS-based medical record and health information management platform for healthcare professionals
Health TechnologySouth Jordan, United States

About Imagenomix AI

What does Imagenomix AI do?

AI based platform offering solutions for cancer diagnosis and treatment.

Where is Imagenomix AI headquartered?

Imagenomix AI is headquartered in New York City, United States.

When was Imagenomix AI founded?

Imagenomix AI was founded in 2022.

Which sector is Imagenomix AI in?

Imagenomix AI operates in Health Technology.

Who are Imagenomix AI's competitors?

Companies similar to Imagenomix AI include Engaging Smiles, Apogee Informatics, and MediConnect Global.